Get started Log in

HVO — hVIVO Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
£40.62m
Enterprise Value
£41.55m
Revenue
£46.77m

Annual Report, Notice of AGM & Directorate Change
12/05/2025 07:00
Brief: Hvivo PLC Announces Revenue Guidance Of £73 Million For 2025
10/04/2025 07:32
Exercise of Options
10/04/2025 07:05
Final results
10/04/2025 07:00
Notice of Results
21/03/2025 07:00
Director/PDMR Shareholding
07/03/2025 07:00
Brief: Hvivo Acquires Cryostore For Up To 3.2 Million Pounds
27/02/2025 07:27
Acquisition of Cryostore for up to £3.2m
27/02/2025 07:00
£2m hMPV characterisation study contract
17/02/2025 07:00
Brief: hVIVO Announces Shionogi's Positive RSV Antiviral Trial Results
05/02/2025 07:21
Shionogi reports positive RSV trial results
05/02/2025 07:00
Brief: hVIVO Signs RSV Contract With Inhalon Biopharma
03/02/2025 07:21
Holding(s) in Company
31/01/2025 13:24
Brief: Rathbones Investment Discloses 12.9% Stake In hVIVO As At Jan 29 - Filing
31/01/2025 07:17
Holding(s) in Company
31/01/2025 07:00
Brief: hVIVO Posts FY Rev Up 11.9% To 62.7 Mln Stg
29/01/2025 07:35
Acquisition: two Clinical Research Units from CRS
29/01/2025 07:01
Trading update
29/01/2025 07:00
Brief: Iliad And Hvivo Sign LOI For Pivotal Phase 3 Trial Of BPZE1 Pertussis Vaccine
27/01/2025 13:12
Brief: hVIVO Signs LoI For Phase 3 Whooping Cough Trial
27/01/2025 07:31